Digest Réseau Comment ça marche
Réseau
/
Sociétés
Sa
Non vérifié

Santhera Pharmaceuticals Holding AG

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologieManagement/Organisation d'EntrepriseMédecine Santé Bien-êtrePublicité/Marketing/Médias/Communication

47 communiqués de presse

Voir tous les communiqués de presse
12/07/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
30/06/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
01/06/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
26/05/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
04/05/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Publishes Agenda for its Annual General Meeting
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
29/04/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Médecine Santé Bien-être
Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
27/04/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Médecine Santé Bien-être
Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
27/04/2026
Biotechnologie
Annonces Économiques
Management/Organisation d'Entreprise
Médecine Santé Bien-être
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
26/04/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0
22/04/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Médecine Santé Bien-être
Santhera Appoints Orlando Oliveira as Chief Executive Officer
Source
Santhera Pharmaceuticals Holding AG
Émetteur
GLOBENEWSWIRE
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0